The utility of prenatal ultrasonography for the detection of congenital masses

Year 2015, Volume: 4 Issue: 2, 1 - 204, 01.05.2015

Doğan Köse Ekrem Ünal Ali Acar Rahmi Örs Yavuz Köksal

Abstract

Objective: Congenital masses are associated with an increased risk for perinatal complications and death; therefore prenatal imagining studies are fundamental to determine the optimal postnatal interventions. Herein we evaluate the usefulness of the prenatal ultrasonography in determination of congenital masses. Method: Nineteen newborn babies with mass were enrolled in this retrospective study. Data of the ultrasonographic diagnosis, gestational age at diagnosis, survival, and histological confirmation of the disease were reviewed. Results: Of the 19 newborn babies 8 male and 11 female with mass, 13 patients were diagnosed prenatally 68% . The location of the masses were abdominal n: 12 , thoracic n: 6 and cranial n: 1 . The ratio of prenatal diagnosis of abdominal, and thoracic mass was established as 10/12 83% , 3/6 50% , respectively. The intracranial mass could not be detected in the prenatal period. Definitive diagnosis of the prenatally detected masses were teratoma in 4 patients, ovary cystadenoma in 2 patients, Wilms tumor in 2 patients, neuroblastoma in 1 patient, and rhabdomyoma in 1 patient. The remaining 3 patients had variety of masses mesenteric cyst, gastroenteric cyst, lymphangioma . Conclusion: Our data shows that abdominal and cystic masses are more easily detected during prenatal periods by ultrasonographic examination.

Keywords

Congenital mass, neonate, prenatal ultrasonography

Doğuştan kitlelerin tespiti için prenatal ultrasonografinin faydası

Abstract

Amaç: Konjenital kitleler artmış perinatal komplikasyon ve ölüm riski ile ilişkilidir. Bu nedenle doğum öncesi görüntüleme çalışmaları, optimum doğum sonrası müdahaleleri belirlemek için esastır. Biz bu yazıda; konjenital kitlelerin belirlenmesinde prenatal ultrasonografinin yararlılığını değerlendirdik. Yöntem: Kitlesi olan 19 yenidoğan bebek bu retrospektif çalışmaya alındı. Ultrasonografik tanı, tanı anındaki gebelik yaşı, hayatta kalma ve hastalığın histolojik doğrulama verileri incelendi. Bulgular: Kitlesi olan bu 19 yenidoğan bebeğin 8 erkek ve 11 kız , 13’ünde %68 tanı prenatal dönemde konuldu. Kitleler abdominal n: 12 , göğüs n: 6 ve kranial n: 1 yerleşimli idi. Abdominal ve torakal kitlelerin prenatal tanı oranları sırasıyla, 10/12 %83 , 3/6 %50 idi. Intrakranial kitle ise prenatal dönemde tespit edilemedi. Prenatal saptanan kitlelerin kesin tanıları, 4 hastada; teratom, 2 hastada; over kistadenomu, 2 hastada; Wilms tümörü, 1 hastada; nöroblastom ve 1 hastada da; rabdomiyom idi. Kalan 3 hastada ise çeşitli mezenter kisti, gastroenterik kist, lenfanjioma kitleler vardı. Sonuç: Bizim veriler abdominal ve kistik kitlelerin prenatal dönemde ultrasonografik inceleme ile daha kolay tespit edildiğini göstermektedir.

Keywords

Konjenital kitle, prenatal ultrasonografi, yenidoğan.

References

• 1. WHO 2010. Global Tuberculosis Control 2010. Available at http://www. whqlibdoc. who. int/publications/2010/9789241564069_eng.
• 2. Dye C, Scheele S, Dolin P, Pathania V , Raviglione MC. Consensus statement. Global burden of tuberculosis:estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282: 677–686.
• 3. Paige C, Bishai WR. Penitentiary or penthouse condo: the tuberculous granuloma from the microbe’s point of view. Cell Microbiol 2010; 12: 301-309.
• 4. Barry CE III, Boshoff HI, Dartois V, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009;7: 845 - 855.
• 5. T.C. Sağlık Bakanlığı Verem Savaş Daire Başkanlığı. Türkiye’de Tüberkülozun Kontrolü için Başvuru Kitabı. 2003;55-57.
• 6. The Mantoux test, Administration, reading and interpretation 2006. Available at http://www.immunisation.ie/en/Downloads/PDFFil e_14983_en.pdf
• 7. Lyng P. The Mantoux Test 2008. Available at http: //web.up.ac.za/sitefiles/file/45/1335/877/Mantoux Flipchart.pdf
• 8. Thompson NJ, Glassroth JL, Snider DE Jr, Farer LS. The booster phenomenon in serial tuberculin testing. Am Rev Respir Dis 1979;119:587-97.
• 9. Horsburgh CR. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004;350:2060-7.
• 10. Harboe M. Antigens of PPD, old tuberculin and autoclaved Mycobacterium bovis BCG studies by crossed immunoelectrophoresis. Am Rev Respir Dis 1981; 124: 80-7.
• 11. Borsuk S, Newcombe J, Mendum TA, Dellagostin OA & McFadden J. Identification of proteins from tuberculin purified protein derivative (PPD) by LCMS/MS. Tuberculosis (Edinb) 2009; 89: 423–430.
• 12. Shingadia D, Novelli V. The tuberculin skin test: a hundred, not out? Arch Dis Child 2008; 93: 189– 190.
• 13. Snider DE Jr. Bacille Calmette-Guerin vaccination and tuberculin skin tests. JAMA 1985; 253: 3438-9.
• 14. Centers for Disease Control. Use of BCG vaccines in the control of tuberculosis: a joint statement by the ACIP and the Advisory Committee for Elimination of Tuberculosis. MMWR Morbid Mortal Wkly Rep 1988; 37: 663-75.
• 15. A Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: 221-247.